Skip to content
naulon
Not checkedNot checked for notices yet.

Oxolinic acid therapy: An effective way to reduce Aeromonas veronii infection in Oreochromis niloticus and improve biochemical and hematological parameters and histopathological lesions

Sinha Priyanka, Abraham Thangapalam Jawahar, Sen Arya and 5 more

Fisheries & Aquatic Life · 2025

doi:10.2478/aopf-2025-0001 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Bacterial diseases such as motile Aeromonas septicemia are major constraints on aquaculture. This study evaluated the efficacy of oral oxolinic acid (OA) therapy at 12 mg kg biomass−1 day−1 for seven days to treat Aeromonas veronii-Av-F (AV) infection in Oreochromis niloticus. The lethal dose of AV for 50% mortality was determined to be 1.81 ×108 cells fish−1. Following intramuscular AV infection at 2.47 × 108 cells fish−1, OA treatment significantly reduced fish mortality and accelerated wound healing. AV infection caused notable changes in biochemical, and hematological parameters, erythrocyte morphology, and histopathological damage to liver and kidney tissues. However, OA therapy facilitated normalizing these parameters more rapidly than in untreated fish, including erythrocyte morphology and histopathological alterations. The study highlights the effectiveness of OA in treating AV infection in O. niloticus. However, available evidence cautions against its overuse and violations of regulations because of its critical importance in human medicine.

Abstract licence: CC BY-NC-ND

References59

  1. 26.

39 more references, whose wording the paper’s licence keeps private.

All 59 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.